Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Pharmacol Biochem Behav. 2012 Jan 20;101(3):417–426. doi: 10.1016/j.pbb.2012.01.010

Figure 3.

Figure 3

Amphetamine treatment on the intake of a saccharin solution by dyad and single-housed rats. Saccharin intake was evaluated during a 1-hour limited access test. Each test was carried out before differential housing while all rats were individually housed (Pre-dyad test), and again when rats were either dyad-housed or single-housed (Dyad). Data for saccharin intake (mg/kg) was calculate as the mean of four test days, and is presented as the mean ± SEM for 13 dyad-housed rats and 11 SiH rats. Statistically significant differences from the pre-dyad test are designated by (*). (Si) Designates significant differences from the single-housed group. Significance level was set at P<.0167 as determined by the Bonferroni test.